These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
781 related articles for article (PubMed ID: 32426387)
1. Artificial intelligence approach fighting COVID-19 with repurposing drugs. Ke YY; Peng TT; Yeh TK; Huang WZ; Chang SE; Wu SH; Hung HC; Hsu TA; Lee SJ; Song JS; Lin WH; Chiang TJ; Lin JH; Sytwu HK; Chen CT Biomed J; 2020 Aug; 43(4):355-362. PubMed ID: 32426387 [TBL] [Abstract][Full Text] [Related]
2. Repurposing old drugs as antiviral agents for coronaviruses. Yang CW; Peng TT; Hsu HY; Lee YZ; Wu SH; Lin WH; Ke YY; Hsu TA; Yeh TK; Huang WZ; Lin JH; Sytwu HK; Chen CT; Lee SJ Biomed J; 2020 Aug; 43(4):368-374. PubMed ID: 32563698 [TBL] [Abstract][Full Text] [Related]
3. Application of Artificial Intelligence in COVID-19 drug repurposing. Mohanty S; Harun Ai Rashid M; Mridul M; Mohanty C; Swayamsiddha S Diabetes Metab Syndr; 2020; 14(5):1027-1031. PubMed ID: 32634717 [TBL] [Abstract][Full Text] [Related]
4. Repurposing drugs against the main protease of SARS-CoV-2: mechanism-based insights supported by available laboratory and clinical data. Chakraborti S; Bheemireddy S; Srinivasan N Mol Omics; 2020 Oct; 16(5):474-491. PubMed ID: 32696772 [TBL] [Abstract][Full Text] [Related]
6. Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses. Theerawatanasirikul S; Kuo CJ; Phecharat N; Chootip J; Lekcharoensuk C; Lekcharoensuk P Antiviral Res; 2020 Oct; 182():104927. PubMed ID: 32910955 [TBL] [Abstract][Full Text] [Related]
7. Interferon-β-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection. Clementi N; Ferrarese R; Criscuolo E; Diotti RA; Castelli M; Scagnolari C; Burioni R; Antonelli G; Clementi M; Mancini N J Infect Dis; 2020 Aug; 222(5):722-725. PubMed ID: 32559285 [TBL] [Abstract][Full Text] [Related]
8. Shape-based Machine Learning Models for the Potential Novel COVID-19 Protease Inhibitors Assisted by Molecular Dynamics Simulation. Nayarisseri A; Khandelwal R; Madhavi M; Selvaraj C; Panwar U; Sharma K; Hussain T; Singh SK Curr Top Med Chem; 2020; 20(24):2146-2167. PubMed ID: 32621718 [TBL] [Abstract][Full Text] [Related]
9. The COVID-19 pandemic. Ciotti M; Ciccozzi M; Terrinoni A; Jiang WC; Wang CB; Bernardini S Crit Rev Clin Lab Sci; 2020 Sep; 57(6):365-388. PubMed ID: 32645276 [TBL] [Abstract][Full Text] [Related]
10. [SARS-CoV-2 and Microbiological Diagnostic Dynamics in COVID-19 Pandemic]. Erensoy S Mikrobiyol Bul; 2020 Jul; 54(3):497-509. PubMed ID: 32755524 [TBL] [Abstract][Full Text] [Related]
11. Molecular Binding Mechanism and Pharmacology Comparative Analysis of Noscapine for Repurposing against SARS-CoV-2 Protease. Kumar N; Sood D; van der Spek PJ; Sharma HS; Chandra R J Proteome Res; 2020 Nov; 19(11):4678-4689. PubMed ID: 32786685 [TBL] [Abstract][Full Text] [Related]
13. Role of biological Data Mining and Machine Learning Techniques in Detecting and Diagnosing the Novel Coronavirus (COVID-19): A Systematic Review. Albahri AS; Hamid RA; Alwan JK; Al-Qays ZT; Zaidan AA; Zaidan BB; Albahri AOS; AlAmoodi AH; Khlaf JM; Almahdi EM; Thabet E; Hadi SM; Mohammed KI; Alsalem MA; Al-Obaidi JR; Madhloom HT J Med Syst; 2020 May; 44(7):122. PubMed ID: 32451808 [TBL] [Abstract][Full Text] [Related]
14. Application of an Artificial Intelligence Trilogy to Accelerate Processing of Suspected Patients With SARS-CoV-2 at a Smart Quarantine Station: Observational Study. Liu PY; Tsai YS; Chen PL; Tsai HP; Hsu LW; Wang CS; Lee NY; Huang MS; Wu YC; Ko WC; Yang YC; Chiang JH; Shen MR J Med Internet Res; 2020 Oct; 22(10):e19878. PubMed ID: 33001832 [TBL] [Abstract][Full Text] [Related]
15. Current status on treatment options for feline infectious peritonitis and SARS-CoV-2 positive cats. Izes AM; Yu J; Norris JM; Govendir M Vet Q; 2020 Dec; 40(1):322-330. PubMed ID: 33138721 [TBL] [Abstract][Full Text] [Related]
16. Drug repurposing in the era of COVID-19: a call for leadership and government investment. Martin JH; Bowden NA Med J Aust; 2020 Jun; 212(10):450-452.e1. PubMed ID: 32372435 [No Abstract] [Full Text] [Related]
17. Repurposing minocycline for COVID-19 management: mechanisms, opportunities, and challenges. Singh H; Kakkar AK; Chauhan P Expert Rev Anti Infect Ther; 2020 Oct; 18(10):997-1003. PubMed ID: 32552044 [TBL] [Abstract][Full Text] [Related]
18. Rapamycin as a potential repurpose drug candidate for the treatment of COVID-19. Husain A; Byrareddy SN Chem Biol Interact; 2020 Nov; 331():109282. PubMed ID: 33031791 [TBL] [Abstract][Full Text] [Related]
19. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL Froggatt HM; Heaton BE; Heaton NS J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534 [TBL] [Abstract][Full Text] [Related]
20. In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus. Eleftheriou P; Amanatidou D; Petrou A; Geronikaki A Molecules; 2020 May; 25(11):. PubMed ID: 32485894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]